Projects per year
Alex is a registered pharmacist who obtained a BSc (Hons) in Pharmacy and a PhD in Drug Delivery from the University of Strathclyde.
Prior to his appointment as a lecturer in 1999, Alex had previously worked in the pharmaceutical industry (Reckitt Benckiser) and as a post-doctoral research fellow in the Department of Immunology, University of Strathclyde, on a WHO-financed project involving the pre-clinical development of parenteral liposomal delivery systems for infectious diseases.
Since his appointment, Alex has developed an extensive research portfolio, encompassing oral and vesicular drug delivery technologies, drug eluting stents, liposomes, vaginal and vaccine delivery systems.
In 2008 Alex was appointed Professor of Pharmacy Practice and has used this science-based practice chair to develop cross disciplinary research integrating and bridging science and practice elements of the pharmacy profession to widen patient access to better medicines and to realise better use of medicines.
Doctor of Philosophy, University of Strathclyde
Award Date: 1 Jan 1998
Bachelor of Pharmacy, University of Strathclyde
Award Date: 1 Jan 1990
1/10/18 → 30/09/22
Project: Research - Studentship
Development of a universal oral influenza vaccine using proprietary non-ionic surfactants, Pharmalinks industrial collaborative project
1/03/06 → …
Project: Internally funded project
Antileishmanial efficacy and tolerability of combined treatment with non-ionic surfactant vesicle formulations of sodium stibogluconate and paromomycin in dogsMiret, J. A., Moreno, J., Nieto, A., Carter, K. C., Mullen, A. B., Ambros, L., Rodríguez, C., San Andrés, M. I. & González, F., 31 Jan 2021, In: Experimental Parasitology . 220, 11 p., 108033.
Research output: Contribution to journal › Article › peer-review
Exploring physicians' views, perceptions and experiences about broad-spectrum antimicrobial prescribing in a tertiary care hospital Riyadh, Saudi Arabia: a qualitative approachAlsaleh, N. A., Al-Omar, H. A., Mayet, A. Y. & Mullen, A. B., 31 Mar 2021, In: Antibiotics. 10, 4, 14 p., 366.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile
Economic benefit and competitive advantage from commercial adoption of an innovative non-invasive delivery method for drugs and vaccines
Impact: Impact - for External Portal › Economic and commerce, Health and welfare - new products, guidelines and servicesFile